HUMA insider transaction filings

Humacyte, Inc. — 42 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-21. Screen HUMA transaction legs live →

FiledFormInsiderReported transactionsSource
2026-08-214Jones Keith Anthony — DirectorPurchase (P): 10,000 @ $0.69EDGAR
2026-08-194Jones Keith Anthony — DirectorPurchase (P): 30,000 @ $0.59EDGAR
2026-06-124Wallace Max N. — DirectorGrant/award (A): 80,000 (derivative) @ $0EDGAR
2026-06-124Niklason Laura E — President, CEO and Director, DirectorGrant/award (A): 80,000 (derivative) @ $0EDGAR
2026-06-124Jones Keith Anthony — DirectorGrant/award (A): 80,000 (derivative) @ $0EDGAR
2026-06-124Green Charles Bruce — DirectorGrant/award (A): 80,000 (derivative) @ $0EDGAR
2026-06-124Seimetz Diane — DirectorGrant/award (A): 80,000 (derivative) @ $0EDGAR
2026-06-124Bamforth John Philip — DirectorGrant/award (A): 80,000 (derivative) @ $0EDGAR
2026-06-124Brown Emery N. — DirectorGrant/award (A): 80,000 (derivative) @ $0EDGAR
2026-06-124Dougan Brady W — DirectorGrant/award (A): 0 (derivative) @ $0EDGAR
2026-06-124Constantino Michael T. — DirectorGrant/award (A): 80,000 (derivative) @ $0EDGAR
2026-06-124Windham-Bannister Susan Richards — DirectorGrant/award (A): 80,000 (derivative) @ $0EDGAR
2026-06-124Sebelius Kathleen — DirectorGrant/award (A): 80,000 (derivative) @ $0EDGAR
2026-05-204Parikh Shamik J — Chief Medical OfficerSale (S): 45,887 @ $0.90EDGAR
2026-05-204Sander Dale A. — CFO and Chief Corp. Dev. OffSale (S): 45,887 @ $0.90EDGAR
2026-05-204Constantino Michael T. — DirectorPurchase (P): 11,000 @ $0.89EDGAR
2026-05-204Sebelius Kathleen — DirectorPurchase (P): 56,818 @ $0.88EDGAR
2025-12-084FRESENIUS MEDICAL CARE HOLDINGS INC /NY/Holdings only — no transactions reportedEDGAR
2025-11-174Sander Dale A. — CFO and Chief Corp. Deve. Off.Grant/award (A): 311,100 @ $0EDGAR
2025-11-174Parikh Shamik J — Chief Medical OfficerGrant/award (A): 311,100 @ $0EDGAR
2025-11-174Dougan Brady W — DirectorGrant/award (A): 311,100 (derivative) @ $0EDGAR
2025-11-174Niklason Laura E — President, CEO and Director, DirectorGrant/award (A): 311,100 (derivative) @ $0EDGAR
2025-08-204Dougan Brady W — DirectorSale (S): 549,360 @ $1.83 · Sale (S): 1,100,000 @ $1.63 · Sale (S): 591,685 @ $1.58EDGAR
2025-08-204Niklason Laura E — President, CEO and Director, DirectorSale (S): 549,360 @ $1.83 · Sale (S): 1,100,000 @ $1.63 · Sale (S): 591,685 @ $1.58EDGAR
2025-06-164Brown Emery N. — DirectorGrant/award (A): 80,000 (derivative) @ $0EDGAR
2025-06-164Jones Keith Anthony — DirectorGrant/award (A): 80,000 (derivative) @ $0EDGAR
2025-06-164Wallace Max N. — DirectorGrant/award (A): 80,000 (derivative) @ $0EDGAR
2025-06-164Niklason Laura E — President, CEO and Director, DirectorGrant/award (A): 0 (derivative) @ $0EDGAR
2025-06-164Dougan Brady W — DirectorGrant/award (A): 0 (derivative) @ $0EDGAR
2025-06-164Green Charles Bruce — DirectorGrant/award (A): 80,000 (derivative) @ $0EDGAR
2025-06-164Bamforth John Philip — DirectorGrant/award (A): 80,000 (derivative) @ $0EDGAR
2025-06-164Seimetz Diane — DirectorGrant/award (A): 80,000 (derivative) @ $0EDGAR
2025-06-164Constantino Michael T. — DirectorGrant/award (A): 80,000 (derivative) @ $0EDGAR
2025-06-164Windham-Bannister Susan Richards — DirectorGrant/award (A): 80,000 (derivative) @ $0EDGAR
2025-06-164Sebelius Kathleen — DirectorGrant/award (A): 80,000 (derivative) @ $0EDGAR
2025-06-164Pope Todd — DirectorGrant/award (A): 80,000 (derivative) @ $0EDGAR
2025-04-154Scheessele William John — Chief Commercial OfficerPurchase (P): 6,493 @ $1.54EDGAR
2025-04-144Parikh Shamik J — Chief Medical OfficerPurchase (P): 7,500 @ $1.55EDGAR
2025-04-144Sander Dale A. — CFO and Chief Corp. Deve. Off.Purchase (P): 20,000 @ $1.53EDGAR
2025-04-084Green Charles Bruce — DirectorPurchase (P): 6,000 @ $1.29EDGAR
2025-04-084Constantino Michael T. — DirectorPurchase (P): 16,000 @ $1.26EDGAR
2025-04-084Sebelius Kathleen — DirectorPurchase (P): 50,000 @ $1.32EDGAR

Recent 8-K events — Humacyte, Inc.

FiledFormItems reportedSource
2026-08-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-318-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2026-06-118-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-108-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-098-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-058-K8.01 — Other EventsEDGAR
2026-05-088-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2026-04-248-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-198-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-198-K2.02 — Results of Operations and Financial Condition
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=HUMA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →